Lexington Diabetic Center Psc is categorized under Internal Medicine Doctors in Lexington, KY and active since 2008.
Lexington Diabetic Center Psc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Michael C Allen at the company’s single location by writing to 3292 Eagle View Lane # 210, Lexington, Kentucky KY 40509 or by phoning (859) 977-8855. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Lexington Diabetic Center Psc |
Contact Person: | Michael C Allen |
Address: | 3292 Eagle View Lane # 210, Lexington, Kentucky 40509 |
Phone Number: | (859) 977-8855 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Lexington Diabetic Center Psc was started in 2008 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Michael C Allen for inquiries that concern Lexington Diabetic Center Psc by calling the company number (859) 977-8855, as your correspondence is most welcome. Additionally, the physical location of the single location of Lexington Diabetic Center Psc can be found at the coordinates 37.999417,-84.441657 as well as the street address 3292 Eagle View Lane # 210 in Lexington, Kentucky 40509.
For its online presence, you may visit Lexington Diabetic Center Psc’s website at and engage with its social media outlets through on Twitter and on Facebook.